RxDoctor Payments Data

Jenna Reid, PA

Physician Assistant · Southaven, MSNPI 1699220905

Payments from drug & device makers

$2,599in general payments, 2019–2025

Across 98 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$428
  • AbbVie$322
  • Teleflex LLC$269
  • Calyxo, Inc.$220
  • Antares Pharma, Inc.$217
  • Medtronic$148
  • plus $995 from 18 others

What the payments were for

  • Food & beverage$2,599100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,599 in reported general payments places this provider in the 75th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$180,581
Medicare patients
422
Services billed
60,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron70$43,935
GemtesaVibegron33$23,028
Tamsulosin Hcl111$1,469
NitrofurantoinNitrofurantoin Macrocrystal24$1,142
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst63$1,052
Finasteride51$700
Ciprofloxacin Hcl84$699
Oxybutynin Chloride ErOxybutynin Chloride56$693
Trimethoprim11$493
Testosterone Cypionate15$392
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$272
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim43$186
Solifenacin Succinate12$133
Fluconazole30$133
Ondansetron OdtOndansetron14$96

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$428$23,02833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Southaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →